Swiss pharmaceutical company Novartis plans to invest a total of $23 billion (CHF18.75 billion) in the US over the next five years to expand production and research. This is likely to be a response to the US government's tariff threats under Donald Trump. +Get the most important news from Switzerland in your inbox With the new... read full story